Considerations for implementation/selection of treatments in CLL/SLL

Considerations for implementation/selection of treatments in Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL). ​
In this presentation, Dr Versha Banerji, researcher and hematologist at the CancerCare Manitoba/University of Manitoba will provide:
A background overview of CLL/SLL
A treatment overview of CLL/SLL

Join the CLL Mentorship Program:
What is the nurse's role in the management of the CLL patient when initiating treatment? What are the main side effects to watch out for when initiating treatment with targeted therapies? What is the initiation protocol for targeted therapies? What is the follow-up for CLL patients at home taking targeted therapy?
You have questions on CLL? You would like to discuss with the speaker Tracy Regimbald? It is possible. Tracy is a research Nurse Manager, at the Clinical Research Unit of the Jewish General Hospital in Montreal. She has over 20 years’ experience working in hematology and with patients.

Length of training : 50 minutes Mentorship Program A...: Yes

  • Important information
  • Recording
  • CLL Mentorship Program
  • Training evaluation form
Completion rules
  • All units must be completed
  • Leads to a certificate with a duration: Forever